http://orcid.org/0000-0002-2767-7746
REFERENCES
- Wang F, Bai R, Yan M, Song M, Yan W. Short-term outcomes of self-expandable metallic stent versus decompression tube for malignant colorectal obstruction: a meta-analysis of clinical data. J Invest Surg. 2019;33(8):755–763.
- Jensen CE, Villanueva JY, Loaiza-Bonilla A. Differences in overall survival and mutation prevalence between right- and left-sided colorectal adenocarcinoma. J Gastrointest Oncol. 2018;9(3):778–784.
- Mik M, Berut M, Dziki L, Trzcinski R, Dziki A. Right- and left-sided colon cancer – clinical and pathological differences of the disease entity in one organ. Arch Med Sci. 2017;13(1):157–162.
- Shen H, Yang J, Huang Q, et al. Different treatment strategies and molecular features between right-sided and left-sided colon cancers. World J Gastroenterol. 2015;21(21):6470–6478.
- Omrane I, Kourda N, Stambouli N, et al. MicroRNAs 146a and 147b biomarkers for colorectal tumor's localization. Biomed Res Int. 2014;2014:1.
- Gopalan V, Pillai S, Ebrahimi F, et al. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance. Mol Carcinog. 2014;53(S1):E36–E44.
- Jones JC, Renfro LA, Al-Shamsi HO, et al. Non-V600BRAF mutations define a clinically distinct molecular subtype of metastatic colorectal cancer. J Clin Oncol. 2017;35:2624–2630.
- Katoh H, Yamashita K, Wang G, Sato T, Nakamura T, Watanabe M. Prognostic significance of preoperative bowel obstruction in stage III colorectal cancer. Ann Surg Oncol. 2011;18(9):2432–2441.
- Maruthachalam K, Lash GE, Shenton BK, Horgan AF. Tumour cell dissemination following endoscopic stent insertion. Br J Surg. 2007;94(9):1151–1154.
- Alix-Panabières C, Schwarzenbach H, Pantel K. Circulating tumor cells and circulating tumor DNA. Annu Rev Med. 2012;63(1):199–215.